This mechanism was confirmed as the basis of P2X7-mediated invasiveness in recent publications covering the negative prognostic role of the receptor in oncological conditions as different as neuroblastoma [44], triple-negative breast cancer [100] and muscle-invasive bladder carcinoma [101]. The gene discussed is P2RX7; the disease is neuroblastoma.